logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Alessandra Bologna

irccs arcispedale s. maria nuova
H指数:21
被引数:3,519

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rational adjustment of dose to reduce adverse reactions (RADAR) in patients with platinum-sensitive recurrent ovarian cancer: Results from the phase II NEWTON trial (ENGOT-ov49)

铂敏感复发性卵巢癌患者中基于合理剂量调整以减少不良反应（RADAR）的结果：来自II期NEWTON试验（ENGOT-ov49）的数据

European Journal of Cancer
IF7.1
2026-03-270
PRE
Nicoletta Colombo; Gabriella Parma; Giulia Tasca; Michele Pio Di Palma; Germana Tognon; Andrea Alberto Lissoni; Roldano Fossati; Luciano Carlucci; Massimo Zucchetti; Cristina Matteo; Annamaria Ferrero; Alessandra Bologna; Mara Mantiero; Pauline Wimberger; Dionyssios Katsaros; Federica Tomao; Francesca Galli; Mariateresa Lapresa; Valentina Guarneri; Silvia Ficarelli
A phase III, randomized, open-label, multicenter study of sacituzumab tirumotecan (sac-TMT) monotherapy vs treatment of physician's choice chemotherapy in patients with endometrial cancer who have received prior chemotherapy and immunotherapy: ENGOT-en23/GOG-3095/MK-2870-005

一项关于sacituzumab tirumotecan（sac-TMT）单药治疗与治疗医师选择化疗方案治疗既往接受过化疗和免疫治疗子宫内膜癌患者的III期、随机、开放标签、多中心研究：ENGOT-en23/GOG-3095/MK-2870-005

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Lorusso, D.; Mirza, M. R.; Martin-Babau, J.; Bologna, A.; Ginesta, M. P. Barretina; Marme, F.; Wampfler, J.; Cibula, D.; Zhu, J.; Hasegawa, K.; Samouelian, V.; Lee, J-Y.; Casarotto, F. C.; Antill, Y.; Lightfoot, M.; Herzog, T. J.; Woodhouse, K.; Cui, Y.; Slomovitz, B. M.; Monk, B. J.
Harmonization of homologous recombination deficiency testing in ovarian cancer: Results from the MITO16A/MaNGO-OV2 trial
EUROPEAN JOURNAL OF CANCER
IF7.1
2024-07-010
PRE
Roma, Cristin; Abate, Riziero Esposito; Sacco, Alessandra; Califano, Daniela; Arenare, Laura; Bergantino, Francesca; Pisano, Carmela; Cecere, Sabrina Chiara; Scambia, Giovanni; Lorusso, Domenica; Artioli, Grazia; Tasca, Giulia; Spina, Anna; Russo, Daniela; Gadducci, Angiolo; De Angelis, Carmine; Bologna, Alessandra; Marchini, Sergio; Capoluongo, Ettore Domenico; Perrone, Francesco; Pignata, Sandro; Normanno, Nicola
Deciphering the immune molecular signature associated with pembrolizumab efficacy in the neoadjuvant setting of Triple-Negative Breast Cancer patients: a single-centre experience

解读与pembrolizumab在三阴性乳腺癌患者新辅助治疗中的疗效相关的免疫分子特征: 单中心经验

CANCER RESEARCH
IF16.6
2024-05-020
PRE
Gasparini, Elisa; Manzotti, Gloria; Ragazzi, Moira; Donati, Benedetta; Torricelli, Federica; Salviato, Elisa; Bisagni, Alessandra; Zanetti, Eleonora; Bologna, Alessandra; Coiro, Saverio; Vacondio, Rita; Ferrari, Guglielmo; Bisagni, Giancarlo; Pinto, Carmine; Ciarrocchi, Alessia; Reggiani, Francesca
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
BRITISH JOURNAL OF CANCER
IF6.8
2023-02-0915
OAAI
Colombo, N.; Gadducci, A.; Sehouli, J.; Rulli, E.; Maenpaa, J.; Sessa, C.; Montes, A.; Ottevanger, N. B.; Berger, R.; Vergote, I.; D'Incalci, M.; Galaz, C. Churruca; Chekerov, R.; Nyvang, G. B.; Riniker, S.; Herbertson, R.; Fossati, R.; Barretina-Ginesta, M. P.; Deryal, M.; Mirza, M. R.; Biagioli, E.; Iglesias, M.; Funari, G.; Romeo, M.; Tasca, G.; Pardo, B.; Tognon, G.; Rubio-Perez, M. J.; DeCensi, A.; De Giorgi, U.; Zola, P.; Panici, P. Benedetti; Aglietta, M.; Arcangeli, V.; Zamagni, C.; Bologna, A.; Westermann, A.; Heinzelmann-Schwarz, V.; Tsibulak, I.; Wimberger, P.; Poveda, A.
The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study
DIAGNOSTICS
IF3.3
2021-03-218
OAAI
Toss, Angela; Piombino, Claudia; Tenedini, Elena; Bologna, Alessandra; Gasparini, Elisa; Tarantino, Vittoria; Filieri, Maria Elisabetta; Cottafavi, Luca; Giovanardi, Filippo; Madrigali, Stefano; Civallero, Monica; Marcheselli, Luigi; Marchi, Isabella; Domati, Federica; Venturelli, Marta; Barbieri, Elena; Grandi, Giovanni; Tagliafico, Enrico; Cortesi, Laura
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study
SCIENTIFIC REPORTS
IF3.9
2020-10-2322
OAAI
Farolfi, Alberto; Scarpi, Emanuela; Greco, Filippo; Bergamini, Alice; Longo, Lucia; Pignata, Sandro; Casanova, Claudia; Cormio, Gennaro; Bologna, Alessandra; Orditura, Michele; Zavallone, Laura; Attademo, Laura; Gall, Valentina; Franzese, Elisena; Pigozzi, Eva; Loizzi, Vera; Giorda, Giorgio; Giardina, Donatella; Cioffi, Raffaella; De Giorgi, Ugo
Maintenance olaparib plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced high-grade ovarian carcinoma (HGOC): Final analysis of second progression-free survival (PFS2) in the phase III PAOLA-1/ENGOT-ov25 trial
ANNALS OF ONCOLOGY
IF65.4
2020-09-0111
OAAI
Gonzalez Martin, A.; Tazi, Y.; Heitz, F.; Montane, L.; Gargiulo, P.; Berger, R.; Yonemori, K.; Vergote, I.; Bologna, A.; Maenpaa, J.; Costan, C.; Canzler, U.; Zamagni, C.; Guerra-Alia, E. M.; Levache, C. B.; Marme, F.; Kalbacher, E.; De Gregorio, N.; Dohollou, N.; Ray-Coquard, I. L.
Progression-free survival (PFS) and overall survival (OS) in HER2-ve advanced breast cancer (ABC) patients (pts) according to the molecular subtype in the era of modern agents. Results from the GIM-13 AMBRA study
CANCER RESEARCH
IF16.6
2020-02-150
PRE
Cazzaniga, Marina Elena; De Placido, Sabino; D'Alonzo, Alessia; Piezzo, Michela; Natoli, Clara; Milani, Andrea; Bologna, Alessandra; Alu, Massimiliano; Turletti, Anna; Pugliese, Palma; Biganzoli, Laura; De Angelis, Claudia; Garrone, Ornella; Marchetti, Paolo; Riccardi, Ferdinando; Bernardo, Antonio; Livi, Lorenzo; Fabi, Alessandra; Taverniti, Cristiana; Romagnoli, Emanuela; Pronzato, Paolo; Mustacchi, Giorgio
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study
ANNALS OF ONCOLOGY
IF65.4
2018-12-01118
OAAI
Conte, P.; Frassoldati, A.; Bisagni, G.; Brandes, A. A.; Donadio, M.; Garrone, O.; Piacentini, F.; Cavanna, L.; Giotta, F.; Aieta, M.; Gebbia, V.; Molino, A.; Musolino, A.; Ferro, A.; Maltoni, R.; Danese, S.; Zamagni, C.; Rimanti, A.; Cagossi, K.; Russo, A.; Pronzato, P.; Giovanardi, F.; Moretti, G.; Lombardo, L.; Schirone, A.; Beano, A.; Amaducci, L.; Bajardi, E. A.; Vicini, R.; Balduzzi, S.; D'Amico, R.; Guarneri, V.; Giarratano, Tommaso; McMahon, Laura; De Salvo, Gian Luca; Dieci, Maria Vittoria; Maiorana, Antonio; Ficarra, Guido; Caggia, Federica; Grisolia, Deborah; Bartolini, Stefania; Lorusso, Vito; Ardito, Raffaele; Tartarone, Alfredo; Vanella, Paola; Taverniti, Cristiana; Porpiglia, Mauro; Spanu, Pier Giorgio; Biglia, Nicoletta; Andreis, Daniele; Piancastelli, Alessandra; Fedeli, Anna; Parra, Hector Soto; Gambaro, Anna Rita; Romito, Sante; Malossi, Alessandra; Gori, Stefania; Miglietta, Loredana; Del Mastro, Lucia; Amoroso, Domenico; Mansutti, Mario; Generali, Daniele; Prati, Giuseppe; Bertolini, Alessandro; Berardi, Rossana; Zanni, Alda; Cottafavi, Luca; Bologna, Alessandra; Naso, Giuseppe; Pancotti, Amedeo; Farci, Daniele; Zoboli, Alessandra; Silva, Rosarita; Laudadio, Lucio; Bordonaro, Roberto; Marenco, Daniela; Dongiovanni, Vincenzo; Baldini, Editta; Saggia, Chiara; Gorzegno, Gabriella; Cariello, Anna; Biganzoli, Laura; Rampello, Elvira
Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)
TARGETED ONCOLOGY
IF4
2018-06-1447
PREAI
Farolfi, Alberto; Petrone, Micaela; Scarpi, Emanuela; Galla, Valentina; Greco, Filippo; Casanova, Claudia; Longo, Lucia; Cormio, Gennaro; Orditura, Michele; Bologna, Alessandra; Zavallone, Laura; Ventriglia, Jole; Franzese, Elisena; Loizzi, Vera; Giardina, Donatella; Pigozzi, Eva; Cioffi, Raffaella; Pignata, Sandro; Giorda, Giorgio; De Giorgi, Ugo
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer

MITO-8，芒果，BGOG-Ov1，AGO-Ovar2.16，ENGOT-Ov1，GCIG研究的生活质量分析，比较部分铂类敏感复发性卵巢癌患者的铂类和非铂类化疗

ANNALS OF ONCOLOGY
IF65.4
2018-05-018
OAAI
Piccirillo, M. C.; Scambia, G.; Bologna, A.; Signoriello, S.; Vergote, I; Baumann, K.; Lorusso, D.; Murgia, V; Sorio, R.; Ferrandina, G.; Sacco, C.; Cormio, G.; Breda, E.; Cinieri, S.; Natale, D.; Mangili, G.; Pisano, C.; Cecere, S. C.; Di Napoli, M.; Salutari, V; Raspagliesi, F.; Arenare, L.; Bergamini, A.; Bryce, J.; Daniele, G.; Gallo, C.; Pignata, S.; Perrone, F.
Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy
ANNALS OF ONCOLOGY
IF65.4
2018-03-0124
OAAI
Friedlander, M.; Rau, J.; Lee, C. K.; Meier, W.; Lesoin, A.; Kim, J-W; Poveda, A.; Buck, M.; Scambia, G.; Shimada, M.; Hilpert, F.; King, M. T.; Debruyne, P.; Bologna, A.; Malander, S.; Monk, B. J.; Petru, E.; Calvert, P.; Herzog, T. J.; Barrett, C.; du Bois, A.

研究方向

暂未获取到该数据
G
Giancarlo Bisagni
H 指数:35论文数:382被引数:5,652
C
Carmine Pinto
H 指数:46论文数:601被引数:1.1万
E
Elisa Gasparini
H 指数:11论文数:76被引数:491
F
Filippo Giovanardi
H 指数:10论文数:47被引数:496
R
Roberto Di Cicilia
H 指数:7论文数:40被引数:516
G
Gabriella Moretti
H 指数:17论文数:172被引数:1,343
S
Sandro Pignata
H 指数:81论文数:901被引数:3.5万
G
Giovanni Scambia
H 指数:117论文数:3,225被引数:9.1万
I
Ignace Vergote
H 指数:135论文数:1,882被引数:8.9万
U
Ugo De Giorgi
H 指数:79论文数:981被引数:2.9万